The global market for Intragastric Balloons was valued at US$27.9 Million in 2024 and is projected to reach US$50.7 Million by 2030, growing at a CAGR of 10.5% from 2024 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions. The report includes the most recent global tariff developments and how they impact the Intragastric Balloons market.
Segments: Type (Single, Dual, Triple); Filling Material (Saline, Gas); End-Use (Hospitals, Clinics, Ambulatory Surgery Centers).
Geographic Regions/Countries: World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.
The analysts continuously track trade developments worldwide, drawing insights from leading global economists and over 200 industry and policy institutions, including think tanks, trade organizations, and national economic advisory bodies. This intelligence is integrated into forecasting models to provide timely, data-driven analysis of emerging risks and opportunities.
Global Intragastric Balloons Market - Key Trends & Drivers Summarized
What Are Intragastric Balloons and Why Are They Gaining Popularity in Weight Loss Treatments?
Intragastric balloons are non-surgical, minimally invasive devices that are temporarily placed in the stomach to help individuals lose weight by reducing their food intake. These balloons are inserted endoscopically and filled with saline or gas, occupying space in the stomach and inducing a feeling of fullness, which helps patients eat smaller portions and lose weight more effectively. Intragastric balloons are gaining popularity in weight loss treatments due to their effectiveness, lower risk compared to bariatric surgery, and the increasing prevalence of obesity worldwide. They offer a reversible option for patients who may not qualify for, or prefer to avoid, more invasive surgical interventions, making them an attractive alternative for weight management.How Are Technological Advancements Shaping the Intragastric Balloons Market?
Technological advancements are significantly shaping the intragastric balloons market, particularly through innovations in balloon design, materials, and deployment techniques. The development of newer-generation balloons that are more durable, adjustable, and easier to insert and remove has improved the safety and efficacy of this treatment. Some intragastric balloons are now designed to be swallowed in capsule form, eliminating the need for endoscopy and sedation, which makes the procedure less invasive and more appealing to a broader range of patients. Additionally, advancements in materials, such as the use of biocompatible and durable polymers, have enhanced the balloon’s ability to withstand the acidic environment of the stomach, reducing the risk of deflation and other complications. These technological innovations are driving the adoption of intragastric balloons as a viable option for weight loss, as they offer patients a safer and more convenient alternative to traditional surgical procedures.Why Is There an Increasing Demand for Intragastric Balloons in Weight Management?
The demand for intragastric balloons is increasing in weight management due to the rising prevalence of obesity, the growing awareness of non-surgical weight loss options, and the desire for less invasive treatments. As obesity rates continue to climb globally, more individuals are seeking effective weight loss solutions that do not involve the risks associated with bariatric surgery. Intragastric balloons are becoming a preferred option for patients who need to lose weight before undergoing other medical procedures or for those who want to avoid the long-term commitment of surgical interventions. The increasing availability of these devices in specialized weight loss clinics and the growing support from healthcare providers are also contributing to the market’s expansion. Additionally, the emphasis on preventive healthcare and the management of obesity-related comorbidities, such as diabetes and cardiovascular disease, is driving demand for intragastric balloons as an effective tool for achieving significant weight loss.What Factors Are Driving the Growth in the Intragastric Balloons Market?
The growth in the intragastric balloons market is driven by several factors closely tied to technological advancements, the rising prevalence of obesity, and the increasing demand for non-surgical weight loss solutions. One of the primary drivers is the growing obesity epidemic, which has led to a surge in demand for effective weight management treatments that are less invasive than traditional bariatric surgery. Technological advancements in balloon design and materials have also played a significant role, making the procedure safer, more effective, and more accessible to a wider range of patients. The expanding network of specialized weight loss clinics and the increasing acceptance of intragastric balloons by healthcare providers are further propelling market growth. Additionally, the trend towards preventive healthcare and the focus on managing obesity-related health risks are driving demand for this minimally invasive treatment option. As these factors continue to shape the healthcare landscape, the intragastric balloons market is expected to experience sustained growth, driven by the need for effective, safe, and convenient weight loss solutions.Report Scope
The report analyzes the Intragastric Balloons market, presented in terms of units. The analysis covers the key segments and geographic regions outlined below.Segments: Type (Single, Dual, Triple); Filling Material (Saline, Gas); End-Use (Hospitals, Clinics, Ambulatory Surgery Centers).
Geographic Regions/Countries: World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.
Key Insights:
- Market Growth: Understand the significant growth trajectory of the Single segment, which is expected to reach US$33.4 Million by 2030 with a CAGR of a 10.0%. The Dual segment is also set to grow at 11.1% CAGR over the analysis period.
- Regional Analysis: Gain insights into the U.S. market, valued at $7.2 Million in 2024, and China, forecasted to grow at an impressive 13.6% CAGR to reach $11.6 Million by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.
Why You Should Buy This Report:
- Detailed Market Analysis: Access a thorough analysis of the Global Intragastric Balloons Market, covering all major geographic regions and market segments.
- Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
- Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Intragastric Balloons Market.
- Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.
Key Questions Answered:
- How is the Global Intragastric Balloons Market expected to evolve by 2030?
- What are the main drivers and restraints affecting the market?
- Which market segments will grow the most over the forecast period?
- How will market shares for different regions and segments change by 2030?
- Who are the leading players in the market, and what are their prospects?
Report Features:
- Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2024 to 2030.
- In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
- Company Profiles: Coverage of players such as Allurion Technologies Inc., Apollo Endosurgery, Inc., Districlass Medical SA, Endalis, Helioscopie and more.
- Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.
Some of the 46 companies featured in this Intragastric Balloons market report include:
- Allurion Technologies Inc.
- Apollo Endosurgery, Inc.
- Districlass Medical SA
- Endalis
- Helioscopie
- Lexel S.R.L
- Medsil
- Obalon Therapeutics, Inc.
- ReShape Lifesciences, Inc.
- Spatz FGIA, Inc.
Tariff Impact Analysis: Key Insights for 2025
Global tariff negotiations across 180+ countries are reshaping supply chains, costs, and competitiveness. This report reflects the latest developments as of April 2025 and incorporates forward-looking insights into the market outlook.The analysts continuously track trade developments worldwide, drawing insights from leading global economists and over 200 industry and policy institutions, including think tanks, trade organizations, and national economic advisory bodies. This intelligence is integrated into forecasting models to provide timely, data-driven analysis of emerging risks and opportunities.
What’s Included in This Edition:
- Tariff-adjusted market forecasts by region and segment
- Analysis of cost and supply chain implications by sourcing and trade exposure
- Strategic insights into geographic shifts
Buyers receive a free July 2025 update with:
- Finalized tariff impacts and new trade agreement effects
- Updated projections reflecting global sourcing and cost shifts
- Expanded country-specific coverage across the industry
Table of Contents
I. METHODOLOGYII. EXECUTIVE SUMMARY2. FOCUS ON SELECT PLAYERSIII. MARKET ANALYSISCANADAITALYSPAINRUSSIAREST OF EUROPESOUTH KOREAREST OF ASIA-PACIFICARGENTINABRAZILMEXICOREST OF LATIN AMERICAIRANISRAELSAUDI ARABIAUNITED ARAB EMIRATESREST OF MIDDLE EASTIV. COMPETITION
1. MARKET OVERVIEW
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
UNITED STATES
JAPAN
CHINA
EUROPE
FRANCE
GERMANY
UNITED KINGDOM
ASIA-PACIFIC
AUSTRALIA
INDIA
LATIN AMERICA
MIDDLE EAST
AFRICA
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Allurion Technologies Inc.
- Apollo Endosurgery, Inc.
- Districlass Medical SA
- Endalis
- Helioscopie
- Lexel S.R.L
- Medsil
- Obalon Therapeutics, Inc.
- ReShape Lifesciences, Inc.
- Spatz FGIA, Inc.
Table Information
Report Attribute | Details |
---|---|
No. of Pages | 196 |
Published | April 2025 |
Forecast Period | 2024 - 2030 |
Estimated Market Value ( USD | $ 27.9 Million |
Forecasted Market Value ( USD | $ 50.7 Million |
Compound Annual Growth Rate | 10.5% |
Regions Covered | Global |